FDA offers statistical guidance for trials impacted by Covid-19
The FDA on Wednesday issued immediately effective guidance offering statistical advice to clinical trial sponsors with the aim of maintaining …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
